CPT1A and head and neck squamous cell carcinoma: Our bioinformatics analysis revealed a robust correlation between the expression of CPT1A and the sensitivity to CPI‐613 treatment in HNSCC cases harboring FAT1 mutations, whereas no such correlation was observed in HNSCC cases with wild‐type FAT1 (Figure S11, Supporting Information).